Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Dynamic Light Scattering (DLS)

Dynamic Light Scattering is a Biophysical Technique that enables particles to be distinguished on the basis of their size. Sygnature Discovery have experience in the utilisation of this technique; using the Viscotek DLS reader, to interrogate the stoichiometry of protein-protein interactions and to identify aggregating compounds or non-specific inhibitors, adding value to our client’s discovery programs via hit validation, protein characterisation and assay troubleshooting.

Dynamic light scattering (DLS) enables an assessment of compound, protein or protein-ligand binding complex aggregation behaviour by measuring the correlation between the intensity of scattered light over a time course. The correlation between time points is used to determine the radii of nanometre-scale objects in solution.

graph to show sub-aggregating concentration and aggregating concentration. Dynamic Light Scattering.

Figure A: dynamic light scattering data for a compound at aggregating and sub-aggregating concentrations, illustrating the raw correlation functions (left) and the corresponding intensity distribution (right).  Aggregation is indicated by peaks to the right of those observed in the buffer blank.

Latest News

View All

First patients dosed in Phase 1a clinical…

Sygnature Discovery Appoints Industry Leaders To Board…

Sygnature Discovery invests £3.75M in Compound Management…

Sygnature Discovery collaborates with Axol Bioscience to…